Exhibit 99
For Immediate Release
Sports Information and Publishing Company
-----------------------------------------
Changes Name to
---------------
In Vivo Medical Diagnostics
---------------------------
Company To Commence Trading with new Symbol: IVVO
----
Inverness, Scotland, September 27, 2004 - Sports Information & Publishing
Corporation (OTCBB: SIPC) has changed its corporate name and symbol to In Vivo
Medical Diagnostics, Inc. and the company will trade with the symbol IVVO,
effective today. The name change more clearly reflects the business of the
company's recent acquisition, Hall Effect Medical Products Inc.
In Vivo Medical Diagnostics is a company that is developing medical diagnostic
products for personal and professional use. Several of these products are based
on technology that utilizes the Hall Effect, a phenomenon discovered more than
100 years ago, for which company scientists are developing practical
applications. Other products are based on proprietary computer algorithms as
they relate to signal processing.
In Vivo Medical Diagnostics, Inc. consists of the former Hall Effect
Technologies Ltd., which is now IVMD (UK) Ltd., and Jopejo Ltd. IVMD is in the
final stage of developing its first groundbreaking medical device for the
cardio-vascular market. Other medical conditions being addressed by IVMD's
patented technology include the diabetes market and those conditions where
imaging is essential. The company's technology is based on the Hall Effect and
although it has been known since 1879 when E.H. Hall discovered it, it is only
through recent developments in semi-conductor technology and computing power
that scientists have been able to analyze the magnetic properties of bone and
tissue, thereby enabling the Hall Effect to be considered in medical uses. In
Vivo Medical Diagnostics has a substantial patent portfolio relating to its
technology. Jopejo Ltd. is also in the late stages of developing new and
technically superior monitoring devices that utilize signal processing for the
late-term pregnancy market.
This press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. In particular, when used in
the preceding discussion, the words "believe", "expects", "projects",
"forecasts", "intends", "will", "anticipated", "could", or "may", and similar
conditional expressions are intended to identify forward-looking statements
within the meaning of the act and are subject to the safe harbor created by the
act. Except for historical information, all of the statements, expectations and
assumptions contained in the foregoing are forward-looking statements that
involve a number of risks and uncertainties.
Contact: In US Bev Jedynak
Martin E. Janis & Company, Inc.
312-943-1100 ext. 12
bjedynak@janispr.com
In UK Brian Cameron
In Vivo Medical Diagnostics
44-1463-667-347